Company Filing History:
Years Active: 1992-1993
Title: Charles D Estin: A Pioneer in Melanoma Vaccine Innovations
Introduction
Charles D Estin, an accomplished inventor based in Bainbridge Island, WA, has significantly contributed to the field of immunology through his innovative work on melanoma vaccines. With two patents to his name, Estin's inventions focus on harnessing the immune response to combat melanoma, a serious form of skin cancer.
Latest Patents
Estin's latest patents revolve around recombinant viruses that encode human melanoma-associated antigens. These peptides or proteins, produced through recombinant DNA techniques or chemical synthetic methods, serve as immunogens within vaccine formulations. The innovative aspect of his work lies in the ability to induce an immune response that specifically targets and destroys melanoma cells within vaccinated individuals. Whether the peptides or proteins are expressed by a recombinant virus or used in inactivated or live virus vaccine formulations, Estin's patents have paved the way for more effective melanoma treatments.
Career Highlights
Currently, Estin is associated with Oncogen, a company dedicated to the development of treatments for cancer. His research and discoveries have not only advanced scientific understanding but have also opened new avenues for therapeutic applications in oncology. Through his patents, Estin exemplifies the blend of scientific research and practical application in the fight against disease.
Collaborations
Throughout his career, Estin has collaborated with prominent colleagues, including Joseph P Brown and Gregory D Plowman. These collaborations have further enriched his research endeavors, leading to innovative approaches in vaccine development for melanoma.
Conclusion
Charles D Estin stands out as a key inventor in the field of melanoma research. His patents reflect a commitment to enhancing vaccine efficacy and advancing therapeutic strategies against cancer. Through his work with Oncogen and collaboration with esteemed colleagues, Estin continues to make significant strides in the battle against melanoma, underscoring the importance of innovation in healthcare.